1Christensen H, Boysen G, Johannesen HH, et al. Deteriorating ischaemic stroke: cytokine, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke. J Nourol Sci, 2002;201(1):1.
2Castillo J, Davalos A, Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet, 1997; 349(9045):79.
3Davalos A, Castillo J, Marugat J, et al. Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology, 2000; 54(8):1568.
4Castillo J, Rama R, Davalos A. Nitric oxide-related brain damage in acute ischemic stroke. Stroke, 2000; 31(4):852.
5Vila N, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke, 2000;31(10):2325.
6Vila N, Castillo J, Davalos A, et al. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke, 2003; 34(3):671.
7Serena J, Leira R, Castillo J, et al.Neurological deterioration in acute lacunar infarction:the role of excitatory and inhibitory neurotransmitters. Stroke, 2001; 32(5):1154.
8Castellanos M, Castillo J, Garcia MM, et al. Inflammation-mediated damage in progressing lacunar infarction.A potential therapeutic target. Stroke, 2002; 33(4):982.
9De Cristobal, Moro MA, avalos A, et al. Neuroprotection effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats. J Neurochem, 2001; 79(2):1.
10Davalos A, Toni D, lweins F, et al. Neurological deterioration in acuteischemic stroke. Potential predictions and associated factors in the european cooperative acute study(ECASS)l. Stroke, 1999; 30(12):2631.
